Evidence map›Paper›PMID 27124305›Full record

ArticlePloS one2016

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.

Sonya A MacParland, Saleh M Fadel, Vesna Mihajlovic, Ali Fawaz, Connie Kim, A K M Nur-Ur Rahman, Jun Liu, Rupert Kaul, Colin Kovacs, Jason Grebely and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Sonya A MacParlandDepartments of Immunology and Medicine, University of Toronto, Toronto, Ontario, Canada.
Saleh M FadelDepartments of Immunology and Medicine, University of Toronto, Toronto, Ontario, Canada.
Vesna MihajlovicDepartments of Immunology and Medicine, University of Toronto, Toronto, Ontario, Canada.
Ali FawazDepartments of Immunology and Medicine, University of Toronto, Toronto, Ontario, Canada.
Connie KimDepartments of Immunology and Medicine, University of Toronto, Toronto, Ontario, Canada.
A K M Nur-Ur RahmanDepartments of Immunology and Medicine, University of Toronto, Toronto, Ontario, Canada.
Jun LiuDepartments of Immunology and Medicine, University of Toronto, Toronto, Ontario, Canada.
Rupert KaulDepartments of Immunology and Medicine, University of Toronto, Toronto, Ontario, Canada.
Colin KovacsMaple Leaf Clinic, Toronto, Ontario, Canada.
Jason GrebelyThe Kirby Institute, UNSW Australia, Sydney, Australia.
Gregory J DoreThe Kirby Institute, UNSW Australia, Sydney, Australia.
David K WongToronto General Hospital, Toronto, Ontario, Canada.
Mario A OstrowskiDepartments of Immunology and Medicine, University of Toronto, Toronto, Ontario, Canada.
University of Toronto · CAMaple Leaf Medical Clinic · CAToronto General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDecreased hepatitis C virus (HCV) clearance, faster cirrhosis progression and higher HCV RNA levels are associated with Human Immunodeficiency virus (HIV) coinfection. The CD4+ T helper cytokines interleukin (IL)-21 and IL-17A are associated with virus control and inflammation, respectively, both important in HCV and HIV disease progression. Here, we examined how antigen-specific production of these cytokines during HCV mono and HIV/HCV coinfection was associated with HCV virus control.

methodsWe measured HCV-specific IL-21 and IL-17A production by transwell cytokine secretion assay in PBMCs from monoinfected and coinfected individuals. Viral control was determined by plasma HCV RNA levels.

resultsIn acutely infected individuals, those able to establish transient/complete HCV viral control tended to have stronger HCV-specific IL-21-production than non-controllers. HCV-specific IL-21 production also correlated with HCV viral decline in acute infection. Significantly stronger HCV-specific IL-21 production was detected in HAART-treated coinfected individuals. HCV-specific IL-17A production was not associated with lower plasma HCV RNA levels in acute or chronic HCV infection and responses were stronger in HIV coinfection. HCV-specific IL-21/ IL-17A responses did not correlate with microbial translocation or fibrosis. Exogenous IL-21 treatment of HCV-specific CD8+ T cells from monoinfected individuals enhanced their function although CD8+ T cells from coinfected individuals were somewhat refractory to the effects of IL-21.

conclusionsThese data show that HCV-specific IL-21 and IL-17A-producing T cells are induced in HIV/HCV coinfection. In early HIV/HCV coinfection, IL-21 may contribute to viral control, and may represent a novel tool to enhance acute HCV clearance in HIV/HCV coinfected individuals.

Indexed as

Immunity, CellularAdultCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCoinfectionCross-Sectional StudiesFemaleGene ExpressionHepacivirusHepatitis C, ChronicHIV-1HIV InfectionsHumansInterleukin-17Interleukin-21InterleukinsIL17A protein, humanInterleukin-17Interleukin-21Interleukins

Identifiers

PMID27124305
PMCPMC4849786
OpenAlexW2342639218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.